Trevor James
The yellow fever vaccine is a live, weakened form of the virus that provides lifelong protection against the disease. It is recommended for people aged 9 months or older who are living in or travelling to areas with a risk of yellow fever transmission, such as Africa and South America. The vaccine is generally safe, with mild and rare side effects, but some individuals may experience severe, life-threatening reactions. While the vaccine helps prevent the spread of the disease, it is unclear whether a vaccinated person can still be contagious and spread the disease to others. This raises the question: Are you contagious after receiving the yellow fever vaccine?
| Characteristics | Values |
|---|---|
| Contagiousness after vaccine | Not contagious |
| Protection duration | Life-long protection |
| Number of doses | One dose |
| Booster dose | Not needed |
| Booster dose recommendation | If it has been 10 years since the last dose |
| Vaccine safety | Safe for most people |
| Side effects | Mild: headache, muscle ache, low-grade fever, tiredness, body aches, vomiting, diarrhoea |
| Rare side effects | Anaphylaxis, encephalitis, meningitis, Guillain-Barré syndrome |
| Severe adverse events | Viscerotropic disease, organ failure, death |
| Risk factors | Age over 60, pregnancy, weakened immune system |
| Risk of severe adverse events | 1.2 cases per 100,000 doses (over 60 years of age) |
| Risk of anaphylaxis | 1.3 cases per 100,000 doses |
Explore related products
![International Certificate of Vaccination with Vinyl Document Holder - World Health Organization Bilingual Version [cards] World Health Organization [Jan 01, 2007]](https://m.media-amazon.com/images/I/61SHjBP1VYL._AC_UY218_.jpg)
What You'll Learn
- The yellow fever vaccine is a live, weakened form of the virus
- One dose is enough to provide lifelong protection for most people
- The vaccine is safe but can cause mild side effects like headaches and fever
- Severe, life-threatening reactions are rare but include anaphylaxis and encephalitis
- The vaccine is recommended for travellers to high-risk areas and may be required for entry to certain countries
The yellow fever vaccine is a live, weakened form of the virus
The vaccine is recommended for people aged 9 months or older who are living in or travelling to areas with a risk of yellow fever transmission, such as Africa and South America. The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) recommend that travellers to these areas get vaccinated to prevent the spread of the disease. Some countries may even require proof of vaccination for entry.
The yellow fever vaccine is typically administered in a single dose, which provides long-lasting protection. A booster dose is usually not needed, but some individuals may consider getting a booster if it has been 10 years or more since their last vaccination, especially if they are travelling to areas with ongoing outbreaks. The vaccine is safe and effective, with mild side effects such as headaches, muscle aches, and low-grade fevers.
While the vaccine is generally safe, there are certain precautions and contraindications to consider. For example, individuals with severe immunodeficiency due to symptomatic HIV/AIDS or other causes may not be suitable candidates for the vaccine. Pregnant women and those who are breastfeeding should also avoid the vaccine unless there is an unavoidable risk of exposure or insufficient protection against mosquito bites. In such cases, it is important to consult with a healthcare professional to weigh the risks and benefits of vaccination.
Overall, the yellow fever vaccine is an important tool in preventing the spread of yellow fever, a potentially life-threatening disease. The live, weakened form of the vaccine provides effective protection for most individuals, helping to protect both the individual and the global community from the disease.
Chicken Egg Vaccines: How Do They Work?
You may want to see also
Explore related products
One dose is enough to provide lifelong protection for most people
The yellow fever vaccine is a live, weakened form of the virus. For most people, a single dose of the yellow fever vaccine is enough to provide long-lasting protection, and a booster dose is not needed. The vaccine provides effective immunity within 10 days for 80-100% of people, and within 30 days for more than 99% of people.
The World Health Organization's Strategic Advisory Group of Experts on Immunization concluded in April 2013 that a single dose is sufficient to confer sustained immunity and lifelong protection. This conclusion was based on a systematic review of published studies on the duration of immunity after a single dose, as well as data suggesting that vaccine failures are extremely rare and do not increase with time since vaccination.
In May 2014, the World Health Assembly adopted the recommendation to remove the 10-year booster dose requirement from the International Health Regulations. This means that, as of June 2016, the recommendation is that a single dose is sufficient for lifelong protection.
However, it's important to note that there may be some exceptions. For example, travellers going to areas with ongoing outbreaks may consider getting a booster dose if it has been 10 years or more since their last vaccination. Additionally, certain countries might have specific requirements for entry, so it's important to check before travelling.
Furthermore, some people may have an increased risk of developing a reaction to the vaccine and should consult their healthcare provider before getting vaccinated. These individuals may include those who are pregnant, nursing, or have a weakened immune system.
Construction Workers: Essential for Vaccine Access
You may want to see also
Explore related products
$22 $28
$13.15 $19.99
The vaccine is safe but can cause mild side effects like headaches and fever
The yellow fever vaccine is a live, weakened form of the virus that helps your body produce its own protection (antibodies) against the virus. It is safe and recommended for people aged 9 months or older who are travelling to or living in areas at risk of yellow fever in Africa and South America. Typically, one dose of the vaccine is enough to provide life-long protection against yellow fever.
Reactions to the yellow fever vaccine are generally mild and include headaches, muscle aches, and low-grade fevers. These side effects can occur from the day of vaccination up until 14 days after vaccination and usually last no more than 3 days.
However, rarely, people may develop severe, sometimes life-threatening reactions to the vaccine. These include allergic reactions with difficulty breathing or swallowing (anaphylaxis), swelling of the brain, spinal cord, or surrounding tissues (encephalitis or meningitis), and Guillain-Barré syndrome, a nervous system disorder that can cause muscle weakness and paralysis.
If you have recently received the yellow fever vaccine and experience fever, headache, tiredness, body aches, vomiting, or diarrhoea, consult your healthcare provider.
The Mystery of Hand, Foot and Mouth: Vaccine Elusive
You may want to see also
Explore related products
Severe, life-threatening reactions are rare but include anaphylaxis and encephalitis
The yellow fever vaccine is a live, weakened form of the virus that is administered via injection. It is recommended for people aged 9 months or older who are travelling to or living in areas at risk of yellow fever in Africa and South America. The vaccine is also advised for those who might come into contact with the virus, such as laboratory workers or healthcare professionals. For most people, a single dose of the yellow fever vaccine provides long-lasting protection, and a booster dose is not typically needed.
However, in rare cases, individuals may experience severe, life-threatening reactions to the vaccine. These reactions include anaphylaxis and encephalitis. Anaphylaxis is a serious allergic reaction that can cause difficulty breathing or swallowing, and it requires immediate medical attention. Encephalitis is the swelling of the brain and can manifest as confusion, irritability, headache, seizures, a stiff neck, or vomiting. Other severe reactions include Guillain-Barré syndrome, a nervous system disorder that can lead to muscle weakness and paralysis, and allergic reactions affecting multiple organs, such as the liver or kidney.
The risk of severe reactions is uncommon, and the yellow fever vaccine is generally considered safe. However, certain individuals may have an increased risk of developing reactions, and it is important to consult a healthcare provider to assess the benefits and risks before receiving the vaccine.
Hepatitis D Vaccine: Is It Possible?
You may want to see also
The vaccine is recommended for travellers to high-risk areas and may be required for entry to certain countries
The yellow fever vaccine is recommended for travellers going to areas with a high risk of yellow fever transmission, such as certain countries in Africa and South America. The World Health Organization (WHO) defines high-risk areas as countries or regions where yellow fever activity has been reported and where vectors and animal reservoirs exist. This includes countries where the disease is endemic or transitional, according to the CDC.
The vaccine is especially important for travellers, as yellow fever is a mosquito-borne disease with a high risk of international spread. A single dose of the vaccine is typically sufficient to provide life-long protection, and it is safe for anyone aged 9 months or older. However, those with weakened immune systems, such as people with symptomatic HIV/AIDS or thymus disorders, are usually excluded from vaccination.
Some countries may require travellers to provide proof of yellow fever vaccination upon entry, especially if arriving from a country on the WHO's list of areas with a risk of yellow fever transmission. These requirements are established by individual countries under the International Health Regulations (IHR) to prevent the importation and transmission of the virus within their borders. It is important for travellers to consult official sources and healthcare professionals to determine the specific entry requirements and health recommendations for their destination.
The CDC recommends receiving the yellow fever vaccine at least 10 days before travelling to a high-risk area. After vaccination, individuals receive an International Certificate of Vaccination or Prophylaxis (ICVP), also known as a "yellow card," which is valid for life. In some cases, travellers may consider getting a booster dose if it has been more than 10 years since their last vaccination or if their previous vaccination occurred during pregnancy, at a young age, or with a weakened immune system.
Childhood Vaccinations: Which Ones Are Absolutely Essential?
You may want to see also
Frequently asked questions
The yellow fever vaccine is a live, weakened form of the virus that causes your immune system to produce antibodies against it. It is recommended for people who are 9 months old or older and are living in or travelling to areas with a high risk of yellow fever.
No, the yellow fever vaccine is a live vaccine that contains a weakened form of the virus, which means that it does not cause disease in healthy people. However, in people with an impaired immune system, the weakened viruses may multiply and cause a yellow fever-like disease.
Mild side effects such as headaches, muscle aches, and low-grade fevers are common and usually last no more than 3 days. In rare cases, severe and sometimes life-threatening reactions such as anaphylaxis, encephalitis, and Guillain-Barré syndrome can occur.
